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ABSTRACT 
A simple, accurate, precise, sensitive, and highly selective ultra violet spectrometer method has been developed for the simultaneous estimation 
of simvastatin and labetalol in bulk and solid dosage form. The estimation of simvastatin was carried out at 239 nm while labetalol was 
estimated at 222.4 nm. The developed method was validated for linearity range, precision, recovery studies and interference study for mixture, 
all these parameter showed the adaptability of the method for the method quality analysis of the drug in bulk and combination formulation. 
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Simvastatin is chemically is 2,2-Dimethyl butanoic acid 
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8ahexahydro- 3,7- dimethyl-8-
[2-[(2R,4R)- tetrahydro-4-hydroxy-6 oxo2H pyran-
2yl]ethyl]1-napthalenyl ester used as a HMGCoA reductase 
inhibitors. Simvastatin belongs to a class of drugs called 
HMG-CoA reductase inhibitors commonly called statins that 
derived synthetically from fermentation products of 
Aspergillus terreus. All statins act by inhibiting 3-hydroxy-3-
methylglutarylcoenzyme (HMG-CoA).A HMG-CoA reductase, 
the rate limiting enzyme of the HMG-CoA reductase 
pathway, the metabolic pathway responsible for the 
endogenous production of cholesterol mainly used for the 
treatment of dyslipidemia and the prevention of 
cardiovascular diseases.Simvastatin is prodrug which is 
converted into its β- hydroxy which inhibits HMG CoA 
reductase (3-hydroxy-3-methyl glutarylCoenzyme A) 
enzyme, responsible for catalysing the conversion of HMG 
CoA to mevalonate a rate limiting step in the synthesis of 
cholesterol in liver.7 
Labetalol HCl is a selective α1 and non-selective β 
adrenergic blocker used to treat high blood 
pressure.Chemically it is 2-hydroxy-5-{[1-hydroxy-2-(4 
phenyl butane-2-lyl) amino] ethyl}benzamide. It has a 
molecular formula of C19H24N2O3.Hcl and a molecular 
weight of 328.40g/mol.8 
 
 
Figure 1 Chemical Structure of Simvastatin Figure 2 Chemical Structure of labetalol HCL 
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MATERIAL AND METHOD 
A UV Visible double beam spectrophotometer ( Shimadzu 
model UV 1800) attached to computer UV probe 2.33 with 
spectral width of 2 nm, wavelength accuracy 0.5 nm and pair 
of 1 cm matched quartz cell was employed.Kindly gifted 
reference standard of simvastatin and labetalol HCL 
(Flemigo pharmaceutical ) were used for study.1,2 
Preparation of standard stock solution 
An accurately weighed quantity of about 100 mg of 
simvastatin was taken in 100 ml volumetric flask dissolved 
in sufficient quantity of 0.25 N NaOH then sonicated for 15 
min and diluted to 100 ml with the same solvent so as to get 
the concentration of 100 μg/ml.s An accurately weighed 
quantity of about 100 mg of labetalol was taken in 100 ml 
volumetric flask dissolved in sufficient quantity of 0.25N 
NaOH then sonicated for 15 min and diluted up to 100 ml 
with the same solvent so as to get the concentration of 
100μg/ml. This stock solution is used for making dilutions 
for calibration curve.1,2,5 
Deternination of λ Max: 
The standard solution of simvastatin and labetalol were 
separately scanned at different concentration in the range of 
200-400 nm and the λ max was determined.1 
Preparation of calibration curve: 
For each drug appropriate aliquots were pipette out from 
standard stock solution into the series of 10 ml volumetric 
flask and the volume was made up to the mark with NaOH to 
get concentration of 2-10 μg/ml of simvastatin and 2-10 
μg/ml of labetalol.Solutions of different concentrations for 
each drug were analysed at their respective wavelengths 
and absorbances were recorded.1,7,8 
Preparation of mixed standard solution: 
Accurately 20 mg of simvastatin and 50 mg labetalol were 
weighed into 100 ml clean and dry volumetric flask and 50 
ml of 0.25 N NaOH was added. 
This mixed standard solution was sonicated for 10 minutes 
and then volume made up to mark with 0.25 N NaOH and 
prepared solution was subjected to UV analysis.1 
Preparation of stock solution of tablet formulation:  
Bi layer Ten tablets of simvastatin and labetalol was 
prepared containing 20 mg of simvastatin and 50 mg of 
labetalol were weighed and finely powdered separately. 
Powder equivalent to 20 mg of simvastatin and 50mg of 
labetalol was weighed and transferred to a sintered glass 
crucible and drug was extracted with three 20 ml quantities 
of 0.25N NaOH, and then final volume of the solution was 
made up to 100 ml with 0.25N NaOH to get a stock solution 
containing 200 μg/ml of simvastatin and 500 μg/ml 
labetalol, and further dilutions were made to get a 
concentration of 2μgm/ml of simvastatin and 5 μg/ml of 
labetalol.1,2,8 
Recovery: 
To evaluate the accuracy, precision and reproducibility of 
the method, known amount of pure drug was added to the 
analyzed sample of tablet powder and the mixture was 
analyzed for the drug content using the proposed method. 
The percentage recovery was found to be within range. The 
recovery experiments indicated the absence of interference 
from the commonly encountered Pharmaceutical additives 
and excipients.1,2 
RESULTS AND DISCUSSION 
The proposed method for determination of simvastatin and 
labetalol showed molar absorptivity 2.038×104 L/mol.cm 
and 2.874 × 104 L /mol cm.The result of UV analysis has 
been shown in Table-1 indicates that the representative 
calibration curve of simvastatin and labetalol were plotted at 
239 nm and 222.4 nm respectively. A linear relationship was 
obtained for both the drugs in the concentration range of 2-
10μg/ml for simvastatin and 2-10μg/ml for labetalol. Linear 
regression of absorbance on concentration gave the 
equation, For, simvastatin 
y = 0.0507– 0.0156 
Correlation coefficient (R2) = 0.991 
For, Labetalol       y =0.0675x + 0.0821 
Correlation coefficient (R2) = 0.997 
The result of UV analysis for tablet formulation has been 
shown in Table-2 indicates that none of the pharmaceutical 
excipients interfered in the estimation of simvastatin and 
labetalol in the UV Spectrophotometric method. The 
calculation of concentration for tablet formulation done by 
simultaneous equation method. The result of recovery study 
shown in Table-3 clearly indicate that the percentage 
recovery was found to be within range.1,2,6 
 
Table 1: 
Parameter simvastatin labetalol 
Detection Wavelength 239 nm 222.4 nm 
Beers Law limit 2-10 μg/ml 2-10 μg/ml 
Molar Absorptivity 2.038×104 L/mol.cm 2.874 × 104 L /mol cm 
Regression Equation Y= MX + C Y= MX + C 
Slope 0.0507 0.0675 
Intercept 0.0156 0.0821 
Correlation Coefficient 0.991 0.997 
 






Tablet simvastatin 20mg 98.20% 
 labetalol 50 mg 99.1% 
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Table 3: Result of recovery study  
    
Formulation Drug Label claim(mg) % Recovery estimated 
    
Tablet simvastatin 20mg 98.3% 
 labetalol 50 mg 98.2% 
 
 
Figure 3: λ max of simvastatin 
 
Figure 4: λ max of labetalol 
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Figure 5: calibration curve for simvastatin 
 
Figure 6: Calibration curve for labetalol 
CONCLUSION 
The Spectrophotometer provides versatile techniques for 
analyse drug in multicomponent pharmaceutical formulation 
in presence of various interferences. The present work 
describes simple, economical and non-interfering 
spectrophotometric method for the estimation of simvastatin 
and labetalol using simultaneous equation method. The 
method was found to be economic, simple, precise, accurate 
and reproducible during analysis of drug formulations 
containing the two drugs.1,2,8  
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